PR89765

CardiacSense's medical watch was handpicked to remotely monitor vital signs and general medical condition of the Israeli Astronaut's vitals while in space

CAESAREA, Israel, May 27, 2021 /PRNewswire=KYODO JBN/ --

  CardiacSense, a Medtech company and the Israel Aerospace Medicine Institute

were selected to send CardiacSense's medical watch to space. The clinically

verified medical grade watch enables continuous, long-term, medical grade and

comfortable patient monitoring without the need to implant invasive cardiac

monitors. CardiacSense is pleased to announce that their medical watch will

monitor Eytan Stibbe's vital signs and general health condition during his

mission to the international space station.

Stibbe's launch is scheduled for February 2022 as part of the Rakia Project by

the Ramon Foundation and in collaboration with the Israel Aerospace Medicine

Institute. The Rakia Project is part of the first private mission to space by

SpaceX. CardiacSense's medical watch, one of the technological scientific

developments that will accompany the mission, will monitor Stibbe's vital signs

and general health condition throughout the mission. CardiacSense's medical

watch already received the CE Mark and the Israeli Ministry of Health

regulatory approval and is expected to be available for commercial use during

the upcoming quarter.

"This is a first-of-its-kind project that was made possible by CardiacSense's

unique and innovative technology, and in turn, reflects the project managers'

confidence in our medical watch and its capabilities," said Eldad Shemesh,

Co-founder and CEO of CardiacSense. "We are proud to be a part of this unique

and special project and accompany Eytan Stibbe while we write Israeli history

in space. This is a voyage to expand the limits of our human and technological

abilities and to redefine telehealth, and for CardiacSense, it serves as proof

that even the sky isn't the limit."

Dr. Eran Schenker, CMIO of the Israel Aerospace Medicine Institute, said: "In

space, many psychological changes occur and affect the human body. Monitoring

vital signs using CardiacSense's medical watch allows, for the first time, for

a simple and continuous observation of many metrics that will greatly help in

understanding the biological processes that astronauts experience while in

space."

About CardiacSense

CardiacSense is a Medtech company that has developed CE approved best-in class,

wrist-wearable sensor technology with the sensitivity and specificity required

for medical diagnosis and monitoring of vital signs, arrhythmias, and chronic

disease deterioration. The medical watch integrates proprietary

patent-protected sensors and software algorithms to provide continuous

measurement of parameters such as core temperature, respiratory rate, blood

pressure, oxygen saturation and heart rate at CE and FDA-mandated accuracies –

providing an alternative to costly and, complex invasive devices. This

addresses the increasing global demand for remote patient monitoring and

tele-health. CardiacSense was founded in 2009 and is headquartered at Caesarea,

Israel.

www.cardiacsense.com

Further information:

Eyal Copitt, CCO

eyal@cardiacsense.com

Photo - https://mma.prnewswire.com/media/1519963/CardiacSense.jpg

Source: CardiacSense